Ibrahim Hegab, MD
Neurology · Richmond, VANPI 1982622825
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.5% of the total across 244 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 11.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,039 and has fallen 90.1% since, to $203 in 2025.
Across 244 payments — averaging $17.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$498
- Novartis$460
- Biohaven Pharmaceuticals, Inc.$367
- Biogen$317
- Sanofi$300
- Teva Pharmaceuticals USA, Inc.$264
- plus $2K from 33 others
Across 1 payment — averaging $1000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Mallinckrodt Hospital Products Inc.$1K
What the payments were for
- Food & beverage$4,27297%
- Education$1113%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 36 | $498 |
| Novartis | 36 | $460 |
| Biohaven Pharmaceuticals, Inc. | 16 | $367 |
| Biogen | 20 | $317 |
| Sanofi | 16 | $300 |
| Teva Pharmaceuticals USA, Inc. | 8 | $264 |
| EMD Serono, Inc. | 21 | $225 |
| AstraZeneca | 8 | $200 |
| Amgen | 5 | $165 |
| Livanova USA, Inc. | 8 | $150 |
| UCB, Inc. | 8 | $141 |
| Supernus Pharmaceuticals, Inc. | 8 | $132 |
| Adamas Pharmaceuticals, Inc. | 1 | $123 |
| Sunovion Pharmaceuticals Inc. | 3 | $112 |
| Kyowa Kirin, Inc. | 5 | $98 |
| Mallinckrodt Hospital Products Inc. | 4 | $95 |
| Eisai Inc. | 4 | $76 |
| Genentech USA, Inc. | 4 | $73 |
| Greenwich Biosciences, Inc. | 4 | $66 |
| Ipsen Biopharmaceuticals, Inc | 2 | $55 |
| CSL Behring | 2 | $47 |
| Pfizer | 2 | $44 |
| GE HealthCare | 2 | $40 |
| Amneal Pharmaceuticals LLC | 3 | $40 |
| Lundbeck LLC | 2 | $36 |
| Neurocrine Biosciences, Inc. | 2 | $33 |
| Avanir Pharmaceuticals, Inc. | 2 | $27 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Argenx US, Inc. | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Mallinckrodt Enterprises LLC | 1 | $17 |
| SK Life Science, Inc. | 1 | $17 |
| Banner Life Sciences, LLC | 1 | $16 |
| Grifols USA, LLC | 1 | $15 |
| MDD US Operations, LLC | 1 | $14 |
| Bristol Myers Squibb | 1 | $14 |
| GRT US Holding, Inc. | 1 | $14 |
| Assertio Therapeutics, Inc. | 1 | $12 |
| Medtronic | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GOCOVRI$123
- NURTEC ODT$114
How this compares
$4,383 in reported general payments places this provider in the 65th percentile of 474 neurology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Emgality PenGalcanezumab-Gnlm | 34 | $24,870 |
| RexultiBrexpiprazole | 12 | $18,877 |
| Aimovig AutoinjectorErenumab-Aooe | 12 | $8,602 |
| Memantine Hcl | 229 | $5,668 |
| Lacosamide | 21 | $3,894 |
| Donepezil Hcl | 206 | $2,320 |
| Galantamine Hbr | 29 | $1,738 |
| Memantine Hcl ErMemantine Hcl | 12 | $1,730 |
| Gabapentin | 138 | $1,461 |
| Pregabalin | 42 | $1,420 |
| Quetiapine Fumarate | 29 | $1,385 |
| Levetiracetam | 44 | $1,339 |
| Duloxetine Hcl | 40 | $764 |
| Buspirone Hcl | 14 | $640 |
| Tizanidine Hcl | 43 | $613 |
Paid to pharmacies, not to this prescriber.
Other neurology in Richmond
- Catherine HamRichmond$603K
- Daniel HardyRichmond$382K
- Myla GoldmanRichmond$132K
- Alan SchulmanRichmond$104K
- Warren FeltonRichmond$96K
- John WittmanRichmond$61K
- Matthew BoyceRichmond$56K
- Leslie CloudRichmond$46K
- Jonathan BekensteinRichmond$37K
- Jessica LehositRichmond$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.